Cell & Gene Therapy Meeting on the Med 2024
In the vanguard of oncology innovation, cell and gene therapies CGT herald a new era in the crusade against cancer. Syneos Health is not just participating in this revolution; we are at its helm. Anchored by decades of trailblazing work in CGT, our role has evolved from observers to major contributors, marking significant progress in the field. With our profound expertise and unwavering dedication to innovation, we are navigating the path towards a future where cancer is not just treated but potentially cured through advanced gene and cell therapies.
Meet with Us
Meet with us at the Cell & Gene Meeting on the Med to share insights, foster partnerships, and collectively push the boundaries of what's possible in CGT. This event is more than a meeting; it's an incubator for ideas and strategies that could define the next generation of oncology treatments. The future of oncology is here, and it's being shaped by the innovations and collaborations in Cell & Gene Therapies.
Our Attendees
Abhi Gupta, Senior Vice President & Head of Cell and Gene Therapy, Syneos Health
Abhi Gupta joined Syneos Health in April 2023 as Senior Vice President, Head of Cell and Gene Therapy. In his role, he drives the development and operationalization of strategic clinical and commercial solutions that accelerate the impact of life-changing genetic medicines for Syneos Health customers and their patients. Prior to Syneos Health, Abhi held various leadership and scientific positions at Pfizer, Regeneron, Citigroup, BMS, and Johnson & Johnson. He is passionate about improving the real-world life experiences of genetic medicine patients and their families and overcoming the pressing challenges of cell and gene therapy research.
Jane K. Bentley, PhD, Vice President, Therapeutic Strategy & Innovation, Oncology and Hematology, Syneos Health
Jane is a distinguished professional in the pharmaceutical industry with over 35 years of experience in oncology drug development. Since May 2016, Jane has been with Syneos Health, where she is passionate about driving strategic innovation in oncology. Her work involves collaborating closely with clients and internal teams to develop and implement solutions-based approaches to drug development, ensuring that new therapies are developed efficiently and effectively. Jane's leadership extends to spearheading cross-functional innovation initiatives, focusing on the patient voice, cell and gene therapy, and rare disease, underlining her dedication to incorporating patient perspectives and addressing the challenges of complex treatments.
Related Content
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
A Holistic Approach to Genetic Medicines is Next for the Life Science Industry
Exploring an Expedited Regulatory Pathway for Cell and Gene Therapies
Cell and Gene Therapy Sponsors Must Overcome Unique Hurdles to Realize Promise to Patients
Strategies for Small Biotech in the Development of Cell Therapy Trials
View more of our insights on Cell & Gene Therapy.
Learn more about our Cell & Gene Therapy expertise.
